Danone has long been operating in Nigeria, and recently invested in developing milk distribution capacity in the country’s ...

Give yourself a headstart: Get full access to The Africa Report on all your devices.

GSK has stopped development of anti-TIGIT antibody belrestotug. The Big Pharma and its partner iTeos Therapeutics took the action after an assessment of the effect on progression-free survival ...

GSK has been found guilty of bringing discredit on the pharma industry after a complainant flagged “a shocking error” in the prescribing information for the JAK inhibitor Omjjara. A person who ...

GSK's generous funding allows Save the Children to respond immediately ... including our biggest programs in the Democratic Republic of Congo, Ethiopia, Kenya, Nigeria and Yemen. Together, we are ...

April 15 (Reuters) - British pharmaceutical giant GSK (GSK.L), opens new tab has not met required ethical and regulatory standards in the marketing and prescription information for its Omjjara ...

From vaccines to vector control, how GSK and its partners are seeking solutions to one of the world's most pressing public health challenges.

Soft earnings didn't appear to concern GSK plc's (LON:GSK) shareholders over the last week. Our analysis suggests that while the profits are soft, the foundations of the business are strong.